Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Biophotonics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The global biophotonics market reached a value of US$ 56.5 Billion in 2020. Looking forward, the market is expected to grow at a CAGR of 10.3% during 2021-2026. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Biophotonics refers to a multidisciplinary research field that uses light-based technologies to study life sciences and medicine. It involves the production and utilization of a light source to detect and manipulate biological materials. Techniques such as spectroscopy, photo-mechanics and fiber optic sensors, which are based on see-through imaging, inside imaging, molecular Spectroscopy, microscopy, analytical sensing and biosensing solutions, are used to study biological tissues, cells and molecules. These techniques aid in emission, detection, absorption, reflection and modification of radiations from biomolecules and biomaterials. As a result, biophotonics finds extensive applications in the fields of life sciences, agriculture, environmental science, dentistry and medicine.
The increasing prevalence of chronic medical ailments, along with the widespread adoption of biophotonics for disease diagnostics, is one of the key factors driving the growth of the market. The rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Furthermore, the widespread adoption of biophotonics from the non-medical sector is creating a positive outlook for the market. It is being used for testing chemicals, toxins and microbial materials for environmental monitoring and defense applications. Additionally, various technological advancements, such as the advent of nanotechnology and novel photoacoustic tomography (PAT) systems, are acting as other growth-inducing factors. These systems use gold and silica nanoparticles for biomedical imaging and accurate sensing of cancer cells in the patients. Other factors, including increasing investments in the development of diagnostic and testing facilities for proteins, nucleic acids and viruses, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
Key Market Segmentation
The analyst provides an analysis of the key trends in each sub-segment of the global biophotonics market, along with forecasts at the global, regional and country level from 2021-2026. The report has categorized the market based on region, technique, technology and application.
Breakup by Technique
- Surface Imaging
- Molecular Spectroscopy
- Microscopy
- Light Therapy
- Biosensors
- Inside Imaging
- See-through Imaging
- Others
Breakup by Technology
- In-Vitro
- In-Vivo
Breakup by Application
- Medical Diagnostics
- Medical Therapeutics
- Material Testing
- Others
Breakup by Region
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The report has also analysed the competitive landscape of the market with some of the key players being Andor Technology Ltd. (Oxford Instruments Plc), BD (Becton, Dickinson and Company), Carl Zeiss AG (Carl-Zeiss-Stiftung), Glenbrook Technologies Inc., Hamamatsu Photonics K.K, Lumenis Ltd., Olympus Corporation, Perkinelmer Inc., Thermo Fisher Scientific Inc. and Zecotek Photonics Inc.
Key Questions Answered in This Report
- How has the global biophotonics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global biophotonics market?
- What are the key regional markets?
- What is the breakup of the market based on the technique?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global biophotonics market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biophotonics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technique
6.1 Surface Imaging
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Molecular Spectroscopy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Microscopy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Light Therapy
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Biosensors
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Inside Imaging
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 See-through Imaging
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Technology
7.1 In-Vitro
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 In-Vivo
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Medical Diagnostics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Medical Therapeutics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Material Testing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Andor Technology Ltd (Oxford Instruments PLC)
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 BD (Becton, Dickinson and Company)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Carl Zeiss AG (Carl-Zeiss-Stiftung)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Glenbrook Technologies Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Hamamatsu Photonics K.K
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Lumenis Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 Olympus Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Perkinelmer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Thermo Fisher Scientific Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Zecotek Photonics Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/puqcqa
